Cord Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationFetal BloodPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousMonocrotophosTransplantation ConditioningGraft vs Host DiseaseStem Cell TransplantationHematologic NeoplasmsPenile ImplantationStem CellsHematopoietic Stem CellsBusulfanBlood BanksTissue DonorsAntigens, CD34Treatment OutcomeHematopoietic Stem Cell MobilizationImmunosuppressive AgentsBone Marrow TransplantationGraft SurvivalCytomegalovirus InfectionsMelphalanGranulocyte Colony-Stimulating FactorRetrospective StudiesTransplantation ChimeraLeukapheresisCombined Modality TherapyCell DifferentiationMyeloablative AgonistsMultiple MyelomaRecurrenceHistocompatibility TestingCyclophosphamideWhole-Body IrradiationHistocompatibilityAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalRemission InductionMice, SCIDKidney TransplantationCells, CulturedLeukemiaHematopoiesisLiver TransplantationLymphoma, Non-HodgkinAntiviral AgentsTime FactorsVidarabineDisease-Free SurvivalSurvival RateGraft vs Leukemia EffectMesenchymal Stem Cell TransplantationAntineoplastic Agents, AlkylatingSurvival AnalysisInfectionLeukemia, Myeloid, AcuteHematologic DiseasesCell TransplantationEtoposideSalvage TherapyTransplantation, IsogeneicThiotepaBlood CellsTransplantationEmbryonic Stem CellsMyelodysplastic SyndromesAmyloidosisHLA AntigensHodgkin DiseaseAnemia, AplasticPOEMS SyndromeFollow-Up StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionBone Marrow CellsHeart TransplantationFatal OutcomeTransplantation ImmunologyPrecursor Cell Lymphoblastic Leukemia-LymphomaOpportunistic InfectionsSpinal CordCytarabineCyclosporineImmunosuppressionAdult Stem CellsMice, Inbred NODLymphomaLymphocyte DepletionVincristineLung TransplantationHepatic Veno-Occlusive DiseaseCarmustineChimerismBone MarrowAcute DiseaseSiblingsUnrelated Donors